Kazutaka G. Nakamura

R3-10, Nagatsuta 4259, Yokohama 226-8503, Japan [2] CREST
Kawaguchi, 3320012, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Effectiveness and Safety of Enfortumab Vedotin Plus Pembrolizumab for Patients Aged 80 Years and Older With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.

Effectiveness and Safety of Enfortumab Vedotin Plus Pembrolizumab for Patients Aged 80 Years and Older With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.

Journal: Anticancer research
Published: May 18, 2026

Comparison of clinical outcomes of cabozantinib plus nivolumab and lenvatinib plus pembrolizumab in patients with metastatic renal cell carcinoma.

Comparison of clinical outcomes of cabozantinib plus nivolumab and lenvatinib plus pembrolizumab in patients with metastatic renal cell carcinoma.

Journal: International urology and nephrology
Published: February 28, 2026

Belzutifan for Metastatic TFE3-Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report.

Belzutifan for Metastatic TFE3-Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report.

Journal: IJU case reports
Published: February 28, 2026

Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma.

Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma.

Journal: In vivo (Athens, Greece)
Published: January 20, 2026

Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan.

Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan.

Journal: Anticancer research
Published: August 11, 2025

A Case of Complete Remission of Bilateral Upper Tract Carcinoma In Situ Following Retrograde Bacillus Calmette-Guérin (BCG) Instillation via Open-Ended Ureteral Catheters After Failure Using Double-J Stents.

A Case of Complete Remission of Bilateral Upper Tract Carcinoma In Situ Following Retrograde Bacillus Calmette-Guérin (BCG) Instillation via Open-Ended Ureteral Catheters After Failure Using Double-J Stents.

Journal: IJU case reports
Published: August 09, 2025

Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case Report.

Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case Report.

Journal: Cancer diagnosis & prognosis
Published: July 19, 2025

Impact of Polypharmacy on Perioperative Outcomes of Robot-assisted Laparoscopic Partial Nephrectomy for Small Renal Masses.

Impact of Polypharmacy on Perioperative Outcomes of Robot-assisted Laparoscopic Partial Nephrectomy for Small Renal Masses.

Journal: In vivo (Athens, Greece)
Published: June 24, 2025

Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 Trial.

Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 Trial.

Journal: In vivo (Athens, Greece)
Published: May 02, 2025

High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinoma.

High real-world incidence of hepatic dysfunction from cabozantinib plus nivolumab for Japanese patients with metastatic renal cell carcinoma.

Journal: Japanese journal of clinical oncology
Published: January 29, 2025

Safety and efficacy of enfortumab vedotin for locally advanced or metastatic urothelial carcinoma in patients aged 80 years and older: A multicenter retrospective study in Japan.

Safety and efficacy of enfortumab vedotin for locally advanced or metastatic urothelial carcinoma in patients aged 80 years and older: A multicenter retrospective study in Japan.

Journal: Journal of geriatric oncology
Published: November 24, 2024

Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma.

Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma.

Journal: International urology and nephrology
Published: November 15, 2024
Showing 1-12 of 35

Last Updated: 09/26/2026